QUANTITATIVE ASSESSMENT OF MESENCHYMAL DIFFERENTIATION FOR METASTATIC RISK PREDICTION OF CLEAR CELL RENAL CARCINOMA (CCRCC)

被引：0
|
作者：
Vilchez, Daniel
Zhang, Bodong
Sanchez, Alejandro
Sirohi, Deepika
Tasdizen, Tolga
Knudsen, Beatrice
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP41-13
引用
收藏
页码：E560 / E560
页数：1
相关论文
共 50 条
  • [1] mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)
    Bastos, Diogo Assed
    Voss, Martin Henner
    Karlo, Christoph
    Ajeti, Albulena
    Patil, Sujata
    Feldman, Darren Richard
    Molina, Ana M.
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [2] Identification of IMDC intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma (ccRCC)
    Guida, A.
    Le Teuff, G.
    Colomba, E.
    Baciarello, G.
    Derosa, L.
    Loriot, Y.
    Fizazi, K.
    Massard, C.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Identification of IMDC intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma (ccRCC)
    Guida, Annalisa
    Le Teuff, Gwenael
    Colomba, Emeline
    Baciarello, Giulia
    Derosa, Lisa
    Loriot, Yohann
    Fizazi, Karim
    Massard, Christophe
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Immune expression profile and sunitinib benefit in metastatic clear cell renal cell carcinoma (ccRCC)
    Reig Torras, O.
    Marin-Aguilera, M.
    Jimenez, N.
    Pare, L.
    Galvan, P.
    Mallofre, C.
    Prat, A.
    Mellado Gonzalez, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] The lipid metabolome of clear cell renal cell carcinoma (CCRCC).
    George, Saby
    Choi, Kyoung-Soo
    Pili, Roberto
    Kazim, Abdul Latif
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] The lipid metabolomic profile of clear cell renal cell carcinoma (CCRCC)
    George, S.
    Choi, K-S
    Miecznikowski, J.
    Pili, R.
    Kazim, A. L.
    BJU INTERNATIONAL, 2012, 110 : 15 - 16
  • [7] Prognostic biomarkers in patients with clear cell renal cell carcinoma (ccRCC)
    Gandur Quiroga, Maria N.
    Knott, Maria E.
    Pulero, Carla
    Pasik, Leonardo
    Alvarez, Ana M.
    Brzezinski, Mariano
    Malagrino, Hector
    Bal de Kier Joffe, Elisa D.
    Puricelli, Lydia I.
    CANCER RESEARCH, 2012, 72
  • [8] Immune-related expression profiles and sunitinib response in metastatic clear cell renal cell carcinoma (ccRCC)
    Reig, Oscar
    Marin, Mercedes
    Jimenez, Natalia
    Pare, Laia
    Galvan, Patricia
    Mallofre, Carmen
    Prat, Aleix
    Mellado, Begona
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Role of quantitative gene expression using RT-PCR in the prediction of recurrence risk in resected T1 clear cell renal cell carcinoma (ccRCC)
    Campbell, S.
    Knezevic, D.
    Maddala, T.
    Novotny, W. F.
    Zhou, M.
    Aydin, H.
    Elson, P.
    Parodi, L.
    Goddard, A. D.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [10] Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)
    Abah, Moses Owoicho
    Ogenyi, Deborah Oganya
    Zhilenkova, Angelina V.
    Essogmo, Freddy Elad
    Tchawe, Yvan Sinclair Ngaha
    Uchendu, Ikenna Kingsley
    Pascal, Akaye Madu
    Nikitina, Natalia M.
    Rusanov, Alexander S.
    Sanikovich, Varvara D.
    Pirogova, Yuliya N.
    Boroda, Alexander
    Moiseeva, Aleksandra V.
    Sekacheva, Marina I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
12345